M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 78.3m EUR

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 18.53 EUR with a low forecast of 15.66 EUR and a high forecast of 23.1 EUR.

Lowest
Price Target
15.66 EUR
222% Upside
Average
Price Target
18.53 EUR
281% Upside
Highest
Price Target
23.1 EUR
375% Upside
Maat Pharma SA Competitors:
Price Targets
BEAM
Beam Therapeutics Inc
210% Upside
SRZN
Surrozen Inc
345% Upside
PYC
PYC Therapeutics Ltd
187% Upside
397030
AprilBio Co Ltd
108% Upside
XGN
Exagen Inc
1% Downside
RAPT
Rapt Therapeutics Inc
448% Upside
IDYA
IDEAYA Biosciences Inc
163% Upside
QURE
Uniqure NV
146% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

N/A
Past Growth
166%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAAT's stock price target?
Price Target
18.53 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 18.53 EUR with a low forecast of 15.66 EUR and a high forecast of 23.1 EUR.

What is Maat Pharma SA's Revenue forecast?
Projected CAGR
166%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

Back to Top